Biotech Values

[masterlongevity]

ACC ph 2 has less than 10% chance.

the phase 2 has been going on since 2007. how many people let a 200 pt ph 2 study run for 6 years without pulling the trigger on ph 3, if it is encouraging? vaccines do not hit the target as hard as monoclonal antibodies and they are still testing the late population that has proven too late with other anti-amyloids. My guess is it will be killed by summer.